Global Hemostasis Valve Market Drivers
The global hemostasis valve market growth is expected to surge over the forecast period, owing to increasing technological advances in hemostasis valves by manufactures. For instance, in 2017, new hemostasis valves HyperSeal and CertuSeal valves for the interventional and diagnostic catheters were introduced by the Freudenberg Medical. Additionally, Freudenberg Medical had introduced innovative FlexSeal valve in 2016. Moreover, for large bore procedure, Freudenberg Medical had introduced new HyperSeal Introducer Sheath with hydrophilic coating.
Furthermore, in May 2019, PhD (“Push, Hold, and Deliver”), which is a polycarbonate hemostasis control valve was launched by Merit Medical Systems, Inc. In addition, to operate the valve with one hand as well as to remove the diagnostic or interventional devices, PhD polycarbonate hemostasis control valve is used. Moreover, dual-seal PhD device is used to minimize the loss of blood without restricting device movement, and allows pressure injections up to 400 psi. These factors are expected to support global hemostasis valve market growth over the forecast period.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients